1. Home
  2. PRTA vs HKD Comparison

PRTA vs HKD Comparison

Compare PRTA & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • HKD
  • Stock Information
  • Founded
  • PRTA 2012
  • HKD 2003
  • Country
  • PRTA Ireland
  • HKD France
  • Employees
  • PRTA N/A
  • HKD N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • HKD Finance: Consumer Services
  • Sector
  • PRTA Health Care
  • HKD Finance
  • Exchange
  • PRTA Nasdaq
  • HKD Nasdaq
  • Market Cap
  • PRTA 809.8M
  • HKD 656.8M
  • IPO Year
  • PRTA N/A
  • HKD 2022
  • Fundamental
  • Price
  • PRTA $5.80
  • HKD $1.82
  • Analyst Decision
  • PRTA Buy
  • HKD
  • Analyst Count
  • PRTA 9
  • HKD 0
  • Target Price
  • PRTA $27.67
  • HKD N/A
  • AVG Volume (30 Days)
  • PRTA 2.2M
  • HKD 1.4M
  • Earning Date
  • PRTA 08-07-2025
  • HKD 01-01-0001
  • Dividend Yield
  • PRTA N/A
  • HKD N/A
  • EPS Growth
  • PRTA N/A
  • HKD 9.93
  • EPS
  • PRTA N/A
  • HKD 0.23
  • Revenue
  • PRTA $137,935,000.00
  • HKD $20,445,000.00
  • Revenue This Year
  • PRTA N/A
  • HKD N/A
  • Revenue Next Year
  • PRTA $30.93
  • HKD N/A
  • P/E Ratio
  • PRTA N/A
  • HKD $7.86
  • Revenue Growth
  • PRTA 54.55
  • HKD N/A
  • 52 Week Low
  • PRTA $4.32
  • HKD $1.65
  • 52 Week High
  • PRTA $25.42
  • HKD $5.80
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 46.16
  • HKD 40.43
  • Support Level
  • PRTA $4.95
  • HKD $1.76
  • Resistance Level
  • PRTA $6.00
  • HKD $1.92
  • Average True Range (ATR)
  • PRTA 0.32
  • HKD 0.16
  • MACD
  • PRTA 0.25
  • HKD -0.03
  • Stochastic Oscillator
  • PRTA 88.59
  • HKD 7.13

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.

Share on Social Networks: